XFOR Butterfly Strategy
XFOR (X4 Pharmaceuticals, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
X4 Pharmaceuticals, Inc. is a biopharmaceutical firm committed to the discovery, development, and commercialization of innovative therapies for uncommon immune system disorders. Its primary drug candidate, XOLREMDI (also known as mavorixafor), is an orally administered, small-molecule antagonist specifically designed to target the chemokine receptor CXCR4. This compound is currently undergoing Phase 3 clinical trials for the management of WHIM syndrome, a rare immunodeficiency characterized by symptoms such as warts, hypogammaglobulinemia, recurrent infections, and myelokathexis. To broaden its global presence, the company has entered into several licensing agreements: A partnership with Abbisko Therapeutics Co Ltd. grants rights for the manufacturing and distribution of XOLREMDI in mainland China, Taiwan, Hong Kong, and Macau. Another agreement with Norgine covers the development, production, and commercialization of mavorixafor across Europe, Australia, and New Zealand. Furthermore, X4 Pharmaceuticals holds a comprehensive agreement with Genzyme Corporation concerning the CXCR4 receptor, allowing for the development and commercialization of licensed compounds for all medical applications, including therapeutic, preventive, and diagnostic uses.
XFOR (X4 Pharmaceuticals, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $404.6M, a beta of 0.35 versus the broader market, a 52-week range of 2.45-4.83, average daily share volume of 598K, a public-listing history dating back to 2017, approximately 45 full-time employees. These structural characteristics shape how XFOR stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.35 indicates XFOR has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a butterfly on XFOR?
A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration.
XFOR snapshot
As of August 14, 2026, spot at $4.20, ATM IV 358.60%, IV rank 74.65%, expected move 102.81%. The butterfly on XFOR below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this butterfly structure on XFOR specifically: XFOR IV at 358.60% is rich versus its 1-year range, which makes a premium-buying XFOR butterfly relatively expensive in absolute-cost terms, with a market-implied 1-standard-deviation move of approximately 102.81% (roughly $4.32 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated XFOR expiries trade a higher absolute premium for lower per-day decay. Position sizing on XFOR should anchor to the underlying notional of $4.20 per share and to the trader's directional view on XFOR stock.
XFOR butterfly setup
The XFOR butterfly below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With XFOR at $4.20 on that close, the first option leg uses a $3.99 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed XFOR chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 XFOR shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $3.99 | N/A |
| Sell 2 | Call | $4.20 | N/A |
| Buy 1 | Call | $4.41 | N/A |
XFOR butterfly risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit.
XFOR butterfly payoff curve
Modeled P&L at expiration across a range of underlying prices for the butterfly on XFOR. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use butterfly on XFOR
Butterflies on XFOR are pinning bets - traders use them when they expect XFOR to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
XFOR thesis for this butterfly
The market-implied 1-standard-deviation range for XFOR extends from approximately $-0.12 on the downside to $8.52 on the upside. A XFOR long call butterfly is a pinning play: it pays maximum at the middle strike if XFOR settles there at expiration, with the wing legs capping both the cost and the maximum loss to the net debit. Current XFOR IV rank near 74.65% sits in the upper third of its 1-year distribution, which historically reverts; this raises the bar for premium-buying structures and lowers it for premium-selling structures on XFOR at 358.60%. As a Healthcare name, XFOR options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to XFOR-specific events.
XFOR butterfly positions are structurally neutral / pin (limited-risk, limited-reward); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. XFOR positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move XFOR alongside the broader basket even when XFOR-specific fundamentals are unchanged. Always rebuild the position from current XFOR chain quotes before placing a trade.
Frequently asked questions
- What is a butterfly on XFOR?
- A butterfly on XFOR is the butterfly strategy applied to XFOR (stock). The strategy is structurally neutral / pin (limited-risk, limited-reward): A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration. With XFOR stock at $4.20 on the most recent close, the strikes shown on this page are snapped to the nearest listed XFOR chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are XFOR butterfly max profit and max loss calculated?
- Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit. For the XFOR butterfly priced from the end-of-day chain at a 30-day expiry (ATM IV 358.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a XFOR butterfly?
- The breakeven for the XFOR butterfly priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The XFOR market-implied 1-standard-deviation expected move in the same options snapshot is approximately 102.81%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a butterfly on XFOR?
- Butterflies on XFOR are pinning bets - traders use them when they expect XFOR to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
- How does current XFOR implied volatility affect this butterfly?
- XFOR ATM IV is at 358.60% with IV rank near 74.65%, which is elevated relative to its 1-year range. Premium-selling structures (covered call, cash-secured put, iron condor) generally look more attractive when IV rank is high; premium-buying structures (long call, long put, debit spreads) are more expensive in that regime.